Abbott Laboratories (ABT)
USD 127.09
(2.08%)
USD 127.09
(2.08%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 40.1 Billion | 43.65 Billion | 43.07 Billion | 34.6 Billion | 31.9 Billion | 30.57 Billion |
| Cost of Revenue | 17.97 Billion | 19.14 Billion | 18.53 Billion | 15 Billion | 13.23 Billion | 12.7 Billion |
| Gross Profit | 22.13 Billion | 24.51 Billion | 24.53 Billion | 19.6 Billion | 18.67 Billion | 17.87 Billion |
| Operating Expenses | 15.71 Billion | 16.14 Billion | 16.11 Billion | 14.24 Billion | 14.14 Billion | 14.22 Billion |
| Selling, General and Administrative Expenses | 10.94 Billion | 11.24 Billion | 11.32 Billion | 9.69 Billion | 9.76 Billion | 9.74 Billion |
| Research and Development Expenses | 2.74 Billion | 2.88 Billion | 2.74 Billion | 2.42 Billion | 2.44 Billion | 2.3 Billion |
| Other Expenses | 1.96 Billion | 2.01 Billion | 2.04 Billion | 2.13 Billion | 1.93 Billion | 139 Million |
| Cost and Expenses | 33.63 Billion | 35.29 Billion | 34.65 Billion | 29.25 Billion | 27.37 Billion | 26.92 Billion |
| Operating Income | 6.47 Billion | 8.36 Billion | 8.42 Billion | 5.35 Billion | 4.53 Billion | 3.65 Billion |
| Interest Expense | 637 Million | 375 Million | 490 Million | 500 Million | 576 Million | 721 Million |
| Income Tax Expense | 941 Million | 1.37 Billion | 1.14 Billion | 497 Million | 390 Million | 539 Million |
| Earnings before Tax | 6.66 Billion | 8.3 Billion | 8.21 Billion | 4.96 Billion | 4.07 Billion | 2.87 Billion |
| Net Income | 5.72 Billion | 6.93 Billion | 7.07 Billion | 4.49 Billion | 3.68 Billion | 2.36 Billion |
| Earnings Per Share Basic | 3.30 | 3.94 | 3.97 | 2.52 | 2.07 | 1.35 |
| Earnings Per Share Diluted | 3.27 | 3.91 | 3.94 | 2.50 | 2.06 | 1.34 |
| Weighted Average Shares Outstanding | 1.73 Billion | 1.75 Billion | 1.77 Billion | 1.77 Billion | 1.76 Billion | 1.75 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.74 Billion | 1.76 Billion | 1.78 Billion | 1.78 Billion | 1.78 Billion | 1.77 Billion |
| Gross Margin | 0.55 | 0.56 | 0.57 | 0.57 | 0.59 | 0.58 |
| EBIT Margin | 0.26 | 0.25 | 0.25 | 0.22 | 0.21 | 0.20 |
| Profit Margin | 0.14 | 0.16 | 0.16 | 0.13 | 0.12 | 0.08 |
| EBITDA | 10.46 Billion | 12.38 Billion | 12.74 Billion | 8.78 Billion | 7.77 Billion | 7.11 Billion |
| Earnings Before Tax Margin | 0.16 | 0.19 | 0.20 | 0.15 | 0.14 | 0.12 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 10.63 Billion | 10.37 Billion | 9.96 Billion | 40.1 Billion | 10.24 Billion | 10.14 Billion |
| Cost of Revenue | 4.69 Billion | 4.57 Billion | 4.42 Billion | 17.97 Billion | 4.98 Billion | 4.6 Billion |
| Gross Profit | 5.93 Billion | 5.8 Billion | 5.54 Billion | 22.13 Billion | 5.25 Billion | 5.53 Billion |
| Operating Expenses | 4.07 Billion | 4.08 Billion | 4.09 Billion | 15.65 Billion | 3.39 Billion | 3.79 Billion |
| Selling, General and Administrative Expenses | 2.89 Billion | 2.91 Billion | 2.94 Billion | - | 2.7 Billion | 2.6 Billion |
| Research and Development Expenses | 713 Million | 698 Million | 679 Million | - | 690 Million | 672 Million |
| Other Expenses | 470 Million | -471 Million | -472 Million | 479 Million | 109 Million | 83 Million |
| Cost and Expenses | 8.77 Billion | 8.65 Billion | 8.51 Billion | 33.63 Billion | 8.37 Billion | 8.4 Billion |
| Operating Income | 1.85 Billion | 1.72 Billion | 1.45 Billion | 6.47 Billion | 1.86 Billion | 1.76 Billion |
| Interest Expense | 51 Million | 58 Million | 61 Million | 637 Million | 235 Million | 166 Million |
| Income Tax Expense | 294 Million | 305 Million | 211 Million | 941 Million | 201 Million | 235 Million |
| Earnings before Tax | 1.94 Billion | 1.6 Billion | 1.43 Billion | 6.66 Billion | 1.79 Billion | 1.67 Billion |
| Net Income | 1.64 Billion | 1.3 Billion | 1.22 Billion | 5.72 Billion | 1.59 Billion | 1.43 Billion |
| Earnings Per Share Basic | 0.94 | 0.75 | 0.71 | - | 0.92 | 0.83 |
| Earnings Per Share Diluted | 0.94 | 0.74 | 0.70 | - | 0.91 | 0.82 |
| Weighted Average Shares Outstanding | 1.74 Billion | 1.73 Billion | 1.73 Billion | 1.74 Billion | 1.73 Billion | 1.73 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.74 Billion | 1.75 Billion | 1.75 Billion | 1.74 Billion | 1.74 Billion | 1.74 Billion |
| Gross Margin | 0.56 | 0.56 | 0.56 | 0.55 | 0.51 | 0.55 |
| EBIT Margin | 0.18 | 0.17 | 0.15 | - | 0.26 | 0.26 |
| Profit Margin | 0.15 | 0.13 | 0.12 | 0.14 | 0.16 | 0.14 |
| EBITDA | 1.94 Billion | 1.72 Billion | 1.45 Billion | - | 2.67 Billion | 2.59 Billion |
| Earnings Before Tax Margin | 0.17 | 0.17 | 0.15 | 0.16 | 0.18 | 0.17 |
AFL
600578
002436
MITT-PB
FXNC
1201